ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antithyroid Drug Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-30T6788
Home | Market Reports | Health| Pharmacy
Global Antithyroid Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Antithyroid Drug Market Research Report 2024

Code: QYRE-Auto-30T6788
Report
May 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co. Ltd
Hunan Hansen Pharmaceutical Co., Ltd.
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd.
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc
Par Pharmaceutical Inc.
Sandoz Pharmaceuticals Inc.

Antithyroid Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antithyroid Drug Market

Antithyroid Drug Market

Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.
The global Antithyroid Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antithyroid Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithyroid Drug.

Report Scope

The Antithyroid Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antithyroid Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithyroid Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antithyroid Drug Market Report

Report Metric Details
Report Name Antithyroid Drug Market
CAGR 5%
Segment by Type
  • Thiourea
  • Iodine and Iodide
  • Radioiodine
  • β Receptor Blockers
Segment by Application
  • Medical Treatment of Hyperthyroidism
  • Preparation for Thyroid Surgery
  • Treatment of Thyroid Crisis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shanghai Huanghai Pharmaceutical Co., Ltd, Merck KGaA, Lomapharm Rudolf Lohmann GmbH KG, Herbrand Pharmaceutical Chemistry Co., Ltd, Beijing Tongjida Pharmaceutical Co., Ltd, Shanghai Zhaohui Pharmaceutical Co., Ltd, Guangzhou Kanghe Pharmaceutical Co., Ltd, Hunan Hansen Pharmaceutical Co., Ltd, World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd, Haimani Pharmaceutical Co., Ltd, Shanghai McLin Biochemical Technology Co., Ltd, Shanghai Yuanye Bio-Technology Co., Ltd, Amgen Inc, AbbVie Deutschland GmbH & Co.KG, Centrix Pharmaceutical Inc., Pfizer Inc., Actavis Totowa LLC, Caraco Pharmaceutical Laboratories, Boca Pharmacal Inc., Heritage Pharmaceuticals Inc., Par Pharmaceutical Inc, Sandoz Pharmaceuticals Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antithyroid Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antithyroid Drug Market report?

Ans: The main players in the Antithyroid Drug Market are Shanghai Huanghai Pharmaceutical Co., Ltd, Merck KGaA, Lomapharm Rudolf Lohmann GmbH KG, Herbrand Pharmaceutical Chemistry Co., Ltd, Beijing Tongjida Pharmaceutical Co., Ltd, Shanghai Zhaohui Pharmaceutical Co., Ltd, Guangzhou Kanghe Pharmaceutical Co., Ltd, Hunan Hansen Pharmaceutical Co., Ltd, World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd, Haimani Pharmaceutical Co., Ltd, Shanghai McLin Biochemical Technology Co., Ltd, Shanghai Yuanye Bio-Technology Co., Ltd, Amgen Inc, AbbVie Deutschland GmbH & Co.KG, Centrix Pharmaceutical Inc., Pfizer Inc., Actavis Totowa LLC, Caraco Pharmaceutical Laboratories, Boca Pharmacal Inc., Heritage Pharmaceuticals Inc., Par Pharmaceutical Inc, Sandoz Pharmaceuticals Inc.

What are the Application segmentation covered in the Antithyroid Drug Market report?

Ans: The Applications covered in the Antithyroid Drug Market report are Medical Treatment of Hyperthyroidism, Preparation for Thyroid Surgery, Treatment of Thyroid Crisis

What are the Type segmentation covered in the Antithyroid Drug Market report?

Ans: The Types covered in the Antithyroid Drug Market report are Thiourea, Iodine and Iodide, Radioiodine, β Receptor Blockers

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antithyroid Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Thiourea
1.2.3 Iodine and Iodide
1.2.4 Radioiodine
1.2.5 β Receptor Blockers
1.3 Market by Application
1.3.1 Global Antithyroid Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Treatment of Hyperthyroidism
1.3.3 Preparation for Thyroid Surgery
1.3.4 Treatment of Thyroid Crisis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antithyroid Drug Market Perspective (2019-2030)
2.2 Antithyroid Drug Growth Trends by Region
2.2.1 Global Antithyroid Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antithyroid Drug Historic Market Size by Region (2019-2024)
2.2.3 Antithyroid Drug Forecasted Market Size by Region (2025-2030)
2.3 Antithyroid Drug Market Dynamics
2.3.1 Antithyroid Drug Industry Trends
2.3.2 Antithyroid Drug Market Drivers
2.3.3 Antithyroid Drug Market Challenges
2.3.4 Antithyroid Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antithyroid Drug Players by Revenue
3.1.1 Global Top Antithyroid Drug Players by Revenue (2019-2024)
3.1.2 Global Antithyroid Drug Revenue Market Share by Players (2019-2024)
3.2 Global Antithyroid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antithyroid Drug Revenue
3.4 Global Antithyroid Drug Market Concentration Ratio
3.4.1 Global Antithyroid Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antithyroid Drug Revenue in 2023
3.5 Antithyroid Drug Key Players Head office and Area Served
3.6 Key Players Antithyroid Drug Product Solution and Service
3.7 Date of Enter into Antithyroid Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antithyroid Drug Breakdown Data by Type
4.1 Global Antithyroid Drug Historic Market Size by Type (2019-2024)
4.2 Global Antithyroid Drug Forecasted Market Size by Type (2025-2030)
5 Antithyroid Drug Breakdown Data by Application
5.1 Global Antithyroid Drug Historic Market Size by Application (2019-2024)
5.2 Global Antithyroid Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antithyroid Drug Market Size (2019-2030)
6.2 North America Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antithyroid Drug Market Size by Country (2019-2024)
6.4 North America Antithyroid Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antithyroid Drug Market Size (2019-2030)
7.2 Europe Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antithyroid Drug Market Size by Country (2019-2024)
7.4 Europe Antithyroid Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antithyroid Drug Market Size (2019-2030)
8.2 Asia-Pacific Antithyroid Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antithyroid Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Antithyroid Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antithyroid Drug Market Size (2019-2030)
9.2 Latin America Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antithyroid Drug Market Size by Country (2019-2024)
9.4 Latin America Antithyroid Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antithyroid Drug Market Size (2019-2030)
10.2 Middle East & Africa Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antithyroid Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Antithyroid Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Huanghai Pharmaceutical Co., Ltd
11.1.1 Shanghai Huanghai Pharmaceutical Co., Ltd Company Detail
11.1.2 Shanghai Huanghai Pharmaceutical Co., Ltd Business Overview
11.1.3 Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.1.4 Shanghai Huanghai Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.1.5 Shanghai Huanghai Pharmaceutical Co., Ltd Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Antithyroid Drug Introduction
11.2.4 Merck KGaA Revenue in Antithyroid Drug Business (2019-2024)
11.2.5 Merck KGaA Recent Development
11.3 Lomapharm Rudolf Lohmann GmbH KG
11.3.1 Lomapharm Rudolf Lohmann GmbH KG Company Detail
11.3.2 Lomapharm Rudolf Lohmann GmbH KG Business Overview
11.3.3 Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Introduction
11.3.4 Lomapharm Rudolf Lohmann GmbH KG Revenue in Antithyroid Drug Business (2019-2024)
11.3.5 Lomapharm Rudolf Lohmann GmbH KG Recent Development
11.4 Herbrand Pharmaceutical Chemistry Co., Ltd
11.4.1 Herbrand Pharmaceutical Chemistry Co., Ltd Company Detail
11.4.2 Herbrand Pharmaceutical Chemistry Co., Ltd Business Overview
11.4.3 Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Introduction
11.4.4 Herbrand Pharmaceutical Chemistry Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.4.5 Herbrand Pharmaceutical Chemistry Co., Ltd Recent Development
11.5 Beijing Tongjida Pharmaceutical Co., Ltd
11.5.1 Beijing Tongjida Pharmaceutical Co., Ltd Company Detail
11.5.2 Beijing Tongjida Pharmaceutical Co., Ltd Business Overview
11.5.3 Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.5.4 Beijing Tongjida Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.5.5 Beijing Tongjida Pharmaceutical Co., Ltd Recent Development
11.6 Shanghai Zhaohui Pharmaceutical Co., Ltd
11.6.1 Shanghai Zhaohui Pharmaceutical Co., Ltd Company Detail
11.6.2 Shanghai Zhaohui Pharmaceutical Co., Ltd Business Overview
11.6.3 Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.6.4 Shanghai Zhaohui Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.6.5 Shanghai Zhaohui Pharmaceutical Co., Ltd Recent Development
11.7 Guangzhou Kanghe Pharmaceutical Co., Ltd
11.7.1 Guangzhou Kanghe Pharmaceutical Co., Ltd Company Detail
11.7.2 Guangzhou Kanghe Pharmaceutical Co., Ltd Business Overview
11.7.3 Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.7.4 Guangzhou Kanghe Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.7.5 Guangzhou Kanghe Pharmaceutical Co., Ltd Recent Development
11.8 Hunan Hansen Pharmaceutical Co., Ltd
11.8.1 Hunan Hansen Pharmaceutical Co., Ltd Company Detail
11.8.2 Hunan Hansen Pharmaceutical Co., Ltd Business Overview
11.8.3 Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.8.4 Hunan Hansen Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.8.5 Hunan Hansen Pharmaceutical Co., Ltd Recent Development
11.9 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
11.9.1 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Company Detail
11.9.2 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Business Overview
11.9.3 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Introduction
11.9.4 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.9.5 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Recent Development
11.10 Haimani Pharmaceutical Co., Ltd
11.10.1 Haimani Pharmaceutical Co., Ltd Company Detail
11.10.2 Haimani Pharmaceutical Co., Ltd Business Overview
11.10.3 Haimani Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.10.4 Haimani Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.10.5 Haimani Pharmaceutical Co., Ltd Recent Development
11.11 Shanghai McLin Biochemical Technology Co., Ltd
11.11.1 Shanghai McLin Biochemical Technology Co., Ltd Company Detail
11.11.2 Shanghai McLin Biochemical Technology Co., Ltd Business Overview
11.11.3 Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Introduction
11.11.4 Shanghai McLin Biochemical Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.11.5 Shanghai McLin Biochemical Technology Co., Ltd Recent Development
11.12 Shanghai Yuanye Bio-Technology Co., Ltd
11.12.1 Shanghai Yuanye Bio-Technology Co., Ltd Company Detail
11.12.2 Shanghai Yuanye Bio-Technology Co., Ltd Business Overview
11.12.3 Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Introduction
11.12.4 Shanghai Yuanye Bio-Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.12.5 Shanghai Yuanye Bio-Technology Co., Ltd Recent Development
11.13 Amgen Inc
11.13.1 Amgen Inc Company Detail
11.13.2 Amgen Inc Business Overview
11.13.3 Amgen Inc Antithyroid Drug Introduction
11.13.4 Amgen Inc Revenue in Antithyroid Drug Business (2019-2024)
11.13.5 Amgen Inc Recent Development
11.14 AbbVie Deutschland GmbH & Co.KG
11.14.1 AbbVie Deutschland GmbH & Co.KG Company Detail
11.14.2 AbbVie Deutschland GmbH & Co.KG Business Overview
11.14.3 AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Introduction
11.14.4 AbbVie Deutschland GmbH & Co.KG Revenue in Antithyroid Drug Business (2019-2024)
11.14.5 AbbVie Deutschland GmbH & Co.KG Recent Development
11.15 Centrix Pharmaceutical Inc.
11.15.1 Centrix Pharmaceutical Inc. Company Detail
11.15.2 Centrix Pharmaceutical Inc. Business Overview
11.15.3 Centrix Pharmaceutical Inc. Antithyroid Drug Introduction
11.15.4 Centrix Pharmaceutical Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.15.5 Centrix Pharmaceutical Inc. Recent Development
11.16 Pfizer Inc.
11.16.1 Pfizer Inc. Company Detail
11.16.2 Pfizer Inc. Business Overview
11.16.3 Pfizer Inc. Antithyroid Drug Introduction
11.16.4 Pfizer Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.16.5 Pfizer Inc. Recent Development
11.17 Actavis Totowa LLC
11.17.1 Actavis Totowa LLC Company Detail
11.17.2 Actavis Totowa LLC Business Overview
11.17.3 Actavis Totowa LLC Antithyroid Drug Introduction
11.17.4 Actavis Totowa LLC Revenue in Antithyroid Drug Business (2019-2024)
11.17.5 Actavis Totowa LLC Recent Development
11.18 Caraco Pharmaceutical Laboratories
11.18.1 Caraco Pharmaceutical Laboratories Company Detail
11.18.2 Caraco Pharmaceutical Laboratories Business Overview
11.18.3 Caraco Pharmaceutical Laboratories Antithyroid Drug Introduction
11.18.4 Caraco Pharmaceutical Laboratories Revenue in Antithyroid Drug Business (2019-2024)
11.18.5 Caraco Pharmaceutical Laboratories Recent Development
11.19 Boca Pharmacal Inc.
11.19.1 Boca Pharmacal Inc. Company Detail
11.19.2 Boca Pharmacal Inc. Business Overview
11.19.3 Boca Pharmacal Inc. Antithyroid Drug Introduction
11.19.4 Boca Pharmacal Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.19.5 Boca Pharmacal Inc. Recent Development
11.20 Heritage Pharmaceuticals Inc.
11.20.1 Heritage Pharmaceuticals Inc. Company Detail
11.20.2 Heritage Pharmaceuticals Inc. Business Overview
11.20.3 Heritage Pharmaceuticals Inc. Antithyroid Drug Introduction
11.20.4 Heritage Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.20.5 Heritage Pharmaceuticals Inc. Recent Development
11.21 Par Pharmaceutical Inc
11.21.1 Par Pharmaceutical Inc Company Detail
11.21.2 Par Pharmaceutical Inc Business Overview
11.21.3 Par Pharmaceutical Inc Antithyroid Drug Introduction
11.21.4 Par Pharmaceutical Inc Revenue in Antithyroid Drug Business (2019-2024)
11.21.5 Par Pharmaceutical Inc Recent Development
11.22 Sandoz Pharmaceuticals Inc.
11.22.1 Sandoz Pharmaceuticals Inc. Company Detail
11.22.2 Sandoz Pharmaceuticals Inc. Business Overview
11.22.3 Sandoz Pharmaceuticals Inc. Antithyroid Drug Introduction
11.22.4 Sandoz Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.22.5 Sandoz Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co. Ltd
Hunan Hansen Pharmaceutical Co., Ltd.
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd.
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc
Par Pharmaceutical Inc.
Sandoz Pharmaceuticals Inc.
List of Tables
    Table 1. Global Antithyroid Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Thiourea
    Table 3. Key Players of Iodine and Iodide
    Table 4. Key Players of Radioiodine
    Table 5. Key Players of β Receptor Blockers
    Table 6. Global Antithyroid Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Antithyroid Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Antithyroid Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Antithyroid Drug Market Share by Region (2019-2024)
    Table 10. Global Antithyroid Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Antithyroid Drug Market Share by Region (2025-2030)
    Table 12. Antithyroid Drug Market Trends
    Table 13. Antithyroid Drug Market Drivers
    Table 14. Antithyroid Drug Market Challenges
    Table 15. Antithyroid Drug Market Restraints
    Table 16. Global Antithyroid Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Antithyroid Drug Market Share by Players (2019-2024)
    Table 18. Global Top Antithyroid Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithyroid Drug as of 2023)
    Table 19. Ranking of Global Top Antithyroid Drug Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Antithyroid Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Antithyroid Drug Product Solution and Service
    Table 23. Date of Enter into Antithyroid Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Antithyroid Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Antithyroid Drug Revenue Market Share by Type (2019-2024)
    Table 27. Global Antithyroid Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Antithyroid Drug Revenue Market Share by Type (2025-2030)
    Table 29. Global Antithyroid Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Antithyroid Drug Revenue Market Share by Application (2019-2024)
    Table 31. Global Antithyroid Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Antithyroid Drug Revenue Market Share by Application (2025-2030)
    Table 33. North America Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Antithyroid Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Antithyroid Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Antithyroid Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Shanghai Huanghai Pharmaceutical Co., Ltd Company Detail
    Table 49. Shanghai Huanghai Pharmaceutical Co., Ltd Business Overview
    Table 50. Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Product
    Table 51. Shanghai Huanghai Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 52. Shanghai Huanghai Pharmaceutical Co., Ltd Recent Development
    Table 53. Merck KGaA Company Detail
    Table 54. Merck KGaA Business Overview
    Table 55. Merck KGaA Antithyroid Drug Product
    Table 56. Merck KGaA Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 57. Merck KGaA Recent Development
    Table 58. Lomapharm Rudolf Lohmann GmbH KG Company Detail
    Table 59. Lomapharm Rudolf Lohmann GmbH KG Business Overview
    Table 60. Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Product
    Table 61. Lomapharm Rudolf Lohmann GmbH KG Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 62. Lomapharm Rudolf Lohmann GmbH KG Recent Development
    Table 63. Herbrand Pharmaceutical Chemistry Co., Ltd Company Detail
    Table 64. Herbrand Pharmaceutical Chemistry Co., Ltd Business Overview
    Table 65. Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Product
    Table 66. Herbrand Pharmaceutical Chemistry Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 67. Herbrand Pharmaceutical Chemistry Co., Ltd Recent Development
    Table 68. Beijing Tongjida Pharmaceutical Co., Ltd Company Detail
    Table 69. Beijing Tongjida Pharmaceutical Co., Ltd Business Overview
    Table 70. Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Product
    Table 71. Beijing Tongjida Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 72. Beijing Tongjida Pharmaceutical Co., Ltd Recent Development
    Table 73. Shanghai Zhaohui Pharmaceutical Co., Ltd Company Detail
    Table 74. Shanghai Zhaohui Pharmaceutical Co., Ltd Business Overview
    Table 75. Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Product
    Table 76. Shanghai Zhaohui Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 77. Shanghai Zhaohui Pharmaceutical Co., Ltd Recent Development
    Table 78. Guangzhou Kanghe Pharmaceutical Co., Ltd Company Detail
    Table 79. Guangzhou Kanghe Pharmaceutical Co., Ltd Business Overview
    Table 80. Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Product
    Table 81. Guangzhou Kanghe Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 82. Guangzhou Kanghe Pharmaceutical Co., Ltd Recent Development
    Table 83. Hunan Hansen Pharmaceutical Co., Ltd Company Detail
    Table 84. Hunan Hansen Pharmaceutical Co., Ltd Business Overview
    Table 85. Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Product
    Table 86. Hunan Hansen Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 87. Hunan Hansen Pharmaceutical Co., Ltd Recent Development
    Table 88. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Company Detail
    Table 89. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Business Overview
    Table 90. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Product
    Table 91. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 92. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Recent Development
    Table 93. Haimani Pharmaceutical Co., Ltd Company Detail
    Table 94. Haimani Pharmaceutical Co., Ltd Business Overview
    Table 95. Haimani Pharmaceutical Co., Ltd Antithyroid Drug Product
    Table 96. Haimani Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 97. Haimani Pharmaceutical Co., Ltd Recent Development
    Table 98. Shanghai McLin Biochemical Technology Co., Ltd Company Detail
    Table 99. Shanghai McLin Biochemical Technology Co., Ltd Business Overview
    Table 100. Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Product
    Table 101. Shanghai McLin Biochemical Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 102. Shanghai McLin Biochemical Technology Co., Ltd Recent Development
    Table 103. Shanghai Yuanye Bio-Technology Co., Ltd Company Detail
    Table 104. Shanghai Yuanye Bio-Technology Co., Ltd Business Overview
    Table 105. Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Product
    Table 106. Shanghai Yuanye Bio-Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 107. Shanghai Yuanye Bio-Technology Co., Ltd Recent Development
    Table 108. Amgen Inc Company Detail
    Table 109. Amgen Inc Business Overview
    Table 110. Amgen Inc Antithyroid Drug Product
    Table 111. Amgen Inc Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 112. Amgen Inc Recent Development
    Table 113. AbbVie Deutschland GmbH & Co.KG Company Detail
    Table 114. AbbVie Deutschland GmbH & Co.KG Business Overview
    Table 115. AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Product
    Table 116. AbbVie Deutschland GmbH & Co.KG Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 117. AbbVie Deutschland GmbH & Co.KG Recent Development
    Table 118. Centrix Pharmaceutical Inc. Company Detail
    Table 119. Centrix Pharmaceutical Inc. Business Overview
    Table 120. Centrix Pharmaceutical Inc. Antithyroid Drug Product
    Table 121. Centrix Pharmaceutical Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 122. Centrix Pharmaceutical Inc. Recent Development
    Table 123. Pfizer Inc. Company Detail
    Table 124. Pfizer Inc. Business Overview
    Table 125. Pfizer Inc. Antithyroid Drug Product
    Table 126. Pfizer Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 127. Pfizer Inc. Recent Development
    Table 128. Actavis Totowa LLC Company Detail
    Table 129. Actavis Totowa LLC Business Overview
    Table 130. Actavis Totowa LLC Antithyroid Drug Product
    Table 131. Actavis Totowa LLC Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 132. Actavis Totowa LLC Recent Development
    Table 133. Caraco Pharmaceutical Laboratories Company Detail
    Table 134. Caraco Pharmaceutical Laboratories Business Overview
    Table 135. Caraco Pharmaceutical Laboratories Antithyroid Drug Product
    Table 136. Caraco Pharmaceutical Laboratories Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 137. Caraco Pharmaceutical Laboratories Recent Development
    Table 138. Boca Pharmacal Inc. Company Detail
    Table 139. Boca Pharmacal Inc. Business Overview
    Table 140. Boca Pharmacal Inc. Antithyroid Drug Product
    Table 141. Boca Pharmacal Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 142. Boca Pharmacal Inc. Recent Development
    Table 143. Heritage Pharmaceuticals Inc. Company Detail
    Table 144. Heritage Pharmaceuticals Inc. Business Overview
    Table 145. Heritage Pharmaceuticals Inc. Antithyroid Drug Product
    Table 146. Heritage Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 147. Heritage Pharmaceuticals Inc. Recent Development
    Table 148. Par Pharmaceutical Inc Company Detail
    Table 149. Par Pharmaceutical Inc Business Overview
    Table 150. Par Pharmaceutical Inc Antithyroid Drug Product
    Table 151. Par Pharmaceutical Inc Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 152. Par Pharmaceutical Inc Recent Development
    Table 153. Sandoz Pharmaceuticals Inc. Company Detail
    Table 154. Sandoz Pharmaceuticals Inc. Business Overview
    Table 155. Sandoz Pharmaceuticals Inc. Antithyroid Drug Product
    Table 156. Sandoz Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
    Table 157. Sandoz Pharmaceuticals Inc. Recent Development
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antithyroid Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Antithyroid Drug Market Share by Type: 2023 VS 2030
    Figure 3. Thiourea Features
    Figure 4. Iodine and Iodide Features
    Figure 5. Radioiodine Features
    Figure 6. β Receptor Blockers Features
    Figure 7. Global Antithyroid Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Antithyroid Drug Market Share by Application: 2023 VS 2030
    Figure 9. Medical Treatment of Hyperthyroidism Case Studies
    Figure 10. Preparation for Thyroid Surgery Case Studies
    Figure 11. Treatment of Thyroid Crisis Case Studies
    Figure 12. Antithyroid Drug Report Years Considered
    Figure 13. Global Antithyroid Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Antithyroid Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Antithyroid Drug Market Share by Region: 2023 VS 2030
    Figure 16. Global Antithyroid Drug Market Share by Players in 2023
    Figure 17. Global Top Antithyroid Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithyroid Drug as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Antithyroid Drug Revenue in 2023
    Figure 19. North America Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Antithyroid Drug Market Share by Country (2019-2030)
    Figure 21. United States Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Antithyroid Drug Market Share by Country (2019-2030)
    Figure 25. Germany Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Antithyroid Drug Market Share by Region (2019-2030)
    Figure 33. China Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Antithyroid Drug Market Share by Country (2019-2030)
    Figure 41. Mexico Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Antithyroid Drug Market Share by Country (2019-2030)
    Figure 45. Turkey Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Shanghai Huanghai Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 48. Merck KGaA Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 49. Lomapharm Rudolf Lohmann GmbH KG Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 50. Herbrand Pharmaceutical Chemistry Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 51. Beijing Tongjida Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 52. Shanghai Zhaohui Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 53. Guangzhou Kanghe Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 54. Hunan Hansen Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 55. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 56. Haimani Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 57. Shanghai McLin Biochemical Technology Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 58. Shanghai Yuanye Bio-Technology Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 59. Amgen Inc Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 60. AbbVie Deutschland GmbH & Co.KG Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 61. Centrix Pharmaceutical Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 62. Pfizer Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 63. Actavis Totowa LLC Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 64. Caraco Pharmaceutical Laboratories Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 65. Boca Pharmacal Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 66. Heritage Pharmaceuticals Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 67. Par Pharmaceutical Inc Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 68. Sandoz Pharmaceuticals Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Irritable Bowel Syndrome Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4R15693
Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Drugs for Treating Metabolic Disorders Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-1N16309
Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Prescription Automation Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29Q15721
Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Global Inflammatory Acne Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-19E18043
Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions